Sort   by:  
 Page size 
UnknownPhase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.
Not available
S-EPMC4348638 | biostudies-literature
UnknownVisualization of the HIV-1 Env glycan shield across scales.
Not available
S-EPMC7668054 | biostudies-literature
UnknownReplication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
Not available
S-EPMC6340019 | biostudies-literature
UnknownComputational analysis of antibody dynamics identifies recent HIV-1 infection.
Not available
S-EPMC5752300 | biostudies-literature
UnknownValidation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS.
Not available
S-EPMC8422903 | biostudies-literature
UnknownSafety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study.
Not available
S-EPMC6687118 | biostudies-literature
UnknownImpact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.
Not available
S-EPMC11125931 | biostudies-literature
UnknownDistinct immune responses in people living with HIV following SARS-CoV-2 recovery.
Not available
S-EPMC12018938 | biostudies-literature
UnknownSafety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.
Not available
S-EPMC9205771 | biostudies-literature
UnknownSafety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
Not available
S-EPMC8516645 | biostudies-literature
Sort   by:  
 Page size